Altogether our in vivo results showed no difference in tumour growth between the CD133high cells and CD133dim LC-42 cells (Figure 6A, B), indicating that the CD133 antigen expressing cells have no growth in vivo advantage when compared to the CD133dim LC-42 cells. The gene discussed is PROM1; the disease is neoplasm.